Literature DB >> 18408744

Modeling atopic dermatitis with increasingly complex mouse models.

Tiffany C Scharschmidt1, Julia A Segre.   

Abstract

Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disorder that affects approximately 15% of children in the United States. A complex disorder, AD is characterized by both skin barrier impairment and immunologic abnormalities, including decreased innate immune function and a polarized adaptive immune response. Mouse models have demonstrated the complex interdependence of immune cell-keratinocyte interactions and teased apart gene-environment relationships in a controlled setting. In this issue, Nagelkerken et al. present a mouse model with transgenic expression of apolipoprotein C1 that disrupts the skin lipid barrier and manifests many hallmark features of AD.

Entities:  

Mesh:

Year:  2008        PMID: 18408744      PMCID: PMC3523690          DOI: 10.1038/sj.jid.5701201

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications.

Authors:  P M Elias; K R Feingold
Journal:  Arch Dermatol       Date:  2001-08

2.  Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.

Authors:  Mao-Qiang Man; Yutaka Hatano; Seung H Lee; Mona Man; Sandra Chang; Kenneth R Feingold; Donald Y M Leung; Walter Holleran; Yoshikazu Uchida; Peter M Elias
Journal:  J Invest Dermatol       Date:  2007-08-02       Impact factor: 8.551

3.  Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice.

Authors:  Makoto Terada; Hiroko Tsutsui; Yasutomo Imai; Koubun Yasuda; Hitoshi Mizutani; Kiyofumi Yamanishi; Masato Kubo; Kiyoshi Matsui; Hajime Sano; Kenji Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-24       Impact factor: 11.205

4.  The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology.

Authors:  David R Bickers; Henry W Lim; David Margolis; Martin A Weinstock; Clifford Goodman; Eric Faulkner; Ciara Gould; Eric Gemmen; Tim Dall
Journal:  J Am Acad Dermatol       Date:  2006-09       Impact factor: 11.527

5.  Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris.

Authors:  R B Presland; D Boggess; S P Lewis; C Hull; P Fleckman; J P Sundberg
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

6.  Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.

Authors:  Vassili Soumelis; Pedro A Reche; Holger Kanzler; Wei Yuan; Gina Edward; Bernhart Homey; Michel Gilliet; Steve Ho; Svetlana Antonenko; Annti Lauerma; Kathleen Smith; Daniel Gorman; Sandra Zurawski; Jon Abrams; Satish Menon; Terri McClanahan; Rene de Waal-Malefyt Rd; Fernando Bazan; Robert A Kastelein; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

7.  Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers.

Authors:  Karin M Aberg; Mao-Qiang Man; Richard L Gallo; Tomas Ganz; Debra Crumrine; Barbara E Brown; Eung-Ho Choi; Dong-Kun Kim; Jens M Schröder; Kenneth R Feingold; Peter M Elias
Journal:  J Invest Dermatol       Date:  2007-10-18       Impact factor: 8.551

8.  12R-lipoxygenase deficiency disrupts epidermal barrier function.

Authors:  Nikolas Epp; Gerhard Fürstenberger; Karsten Müller; Silvia de Juanes; Michael Leitges; Ingrid Hausser; Florian Thieme; Gerhard Liebisch; Gerd Schmitz; Peter Krieg
Journal:  J Cell Biol       Date:  2007-04-02       Impact factor: 10.539

9.  Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema.

Authors:  Aileen Sandilands; Ana Terron-Kwiatkowski; Peter R Hull; Gráinne M O'Regan; Timothy H Clayton; Rosemarie M Watson; Thomas Carrick; Alan T Evans; Haihui Liao; Yiwei Zhao; Linda E Campbell; Matthias Schmuth; Robert Gruber; Andreas R Janecke; Peter M Elias; Maurice A M van Steensel; Ivo Nagtzaam; Michel van Geel; Peter M Steijlen; Colin S Munro; Daniel G Bradley; Colin N A Palmer; Frances J D Smith; W H Irwin McLean; Alan D Irvine
Journal:  Nat Genet       Date:  2007-04-08       Impact factor: 38.330

10.  Cytokine modulation of atopic dermatitis filaggrin skin expression.

Authors:  Michael D Howell; Byung Eui Kim; Peisong Gao; Audrey V Grant; Mark Boguniewicz; Anna Debenedetto; Lynda Schneider; Lisa A Beck; Kathleen C Barnes; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2007-05-23       Impact factor: 10.793

View more
  12 in total

1.  Atopic dermatitis and the stratum corneum: part 3: the immune system in atopic dermatitis.

Authors:  Jacquelyn Levin; Sheila Fallon Friedlander; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-12

2.  Epidermal ablation of Dlx3 is linked to IL-17-associated skin inflammation.

Authors:  Joonsung Hwang; Ryosuke Kita; Hyouk-Soo Kwon; Eung Ho Choi; Seung Hun Lee; Mark C Udey; Maria I Morasso
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

3.  Ulcerative Dermatitis in C57BL/6NCrl Mice on a Low-Fat or High-Fat Diet With or Without a Mineralized Red-Algae Supplement.

Authors:  Anna L Hampton; Muhammad N Aslam; Madhav K Naik; Ingrid L Bergin; Ron M Allen; Ronald A Craig; Steve L Kunkel; Indiradevi Veerapaneni; Tejaswi Paruchuri; Kathleen A Patterson; Edward D Rothman; Gerald A Hish; James Varani; Howard G Rush
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-09       Impact factor: 1.232

4.  Development of atopic dermatitis-like skin disease from the chronic loss of epidermal caspase-8.

Authors:  Christopher Li; Samuel Lasse; Pedro Lee; Manando Nakasaki; Shih-Wei Chen; Kenshi Yamasaki; Richard L Gallo; Colin Jamora
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

5.  Longitudinal Evaluation of the Skin Microbiome and Association with Microenvironment and Treatment in Canine Atopic Dermatitis.

Authors:  Charles W Bradley; Daniel O Morris; Shelley C Rankin; Christine L Cain; Ana M Misic; Timothy Houser; Elizabeth A Mauldin; Elizabeth A Grice
Journal:  J Invest Dermatol       Date:  2016-02-06       Impact factor: 8.551

6.  Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens.

Authors:  Tiffany C Scharschmidt; Mao-Qiang Man; Yutaka Hatano; Debra Crumrine; Roshan Gunathilake; John P Sundberg; Kathleen A Silva; Theodora M Mauro; Melanie Hupe; Soyun Cho; Yan Wu; Anna Celli; Matthias Schmuth; Kenneth R Feingold; Peter M Elias
Journal:  J Allergy Clin Immunol       Date:  2009-09       Impact factor: 10.793

Review 7.  Topical herbal application in the management of atopic dermatitis: a review of animal studies.

Authors:  Younghee Yun; Kyuseok Kim; Inhwa Choi; Seong-Gyu Ko
Journal:  Mediators Inflamm       Date:  2014-06-15       Impact factor: 4.711

8.  Differences in Genetic Variations Between Treatable and Recalcitrant Atopic Dermatitis in Korean.

Authors:  Myungsoo Jun; Hye Young Wang; Solam Lee; Eunhee Choi; Hyeyoung Lee; Eung Ho Choi
Journal:  Allergy Asthma Immunol Res       Date:  2018-05       Impact factor: 5.764

Review 9.  Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond.

Authors:  Elena V Fuior; Anca V Gafencu
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

10.  Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.

Authors:  Zhixing Wang; Ling-Juan Zhang; Gunjan Guha; Shan Li; Kateryna Kyrylkova; Chrissa Kioussi; Mark Leid; Gitali Ganguli-Indra; Arup K Indra
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.